These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7970013)

  • 1. Summary of combined clinical analysis of controlled clinical trials with tizanidine.
    Wallace JD
    Neurology; 1994 Nov; 44(11 Suppl 9):S60-8; discussion S68-9. PubMed ID: 7970013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nightly sublingual tizanidine HCl in multiple sclerosis: clinical efficacy and safety.
    Vakhapova V; Auriel E; Karni A
    Clin Neuropharmacol; 2010 May; 33(3):151-4. PubMed ID: 20502134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects.
    Henney HR; Shah J
    Clin Ther; 2007 Apr; 29(4):661-9. PubMed ID: 17617289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of food on the single-dose pharmacokinetics/pharmacodynamics of tizanidine capsules and tablets in healthy volunteers.
    Shah J; Wesnes KA; Kovelesky RA; Henney HR
    Clin Ther; 2006 Sep; 28(9):1308-17. PubMed ID: 17062304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacological management of spasticity.
    Saulino M; Jacobs BW
    J Neurosci Nurs; 2006 Dec; 38(6):456-9. PubMed ID: 17233517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum neurotoxin versus tizanidine in upper limb spasticity: a placebo-controlled study.
    Simpson DM; Gracies JM; Yablon SA; Barbano R; Brashear A;
    J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):380-5. PubMed ID: 18977811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury.
    Kamen L; Henney HR; Runyan JD
    Curr Med Res Opin; 2008 Feb; 24(2):425-39. PubMed ID: 18167175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinically relevant review of tizanidine hydrochloride dose relationships to pharmacokinetics, drug safety and effectiveness in healthy subjects and patients.
    Henney HR; Runyan JD
    Int J Clin Pract; 2008 Feb; 62(2):314-24. PubMed ID: 18199279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative bioavailability of tizanidine hydrochloride capsule formulation compared with capsule contents administered in applesauce: a single-dose, open-label, randomized, two-way, crossover study in fasted healthy adult subjects.
    Henney HR; Fitzpatrick A; Stewart J; Runyan JD
    Clin Ther; 2008 Dec; 30(12):2263-71. PubMed ID: 19167586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spasticity: revisiting the role and the individual value of several pharmacological treatments.
    Lapeyre E; Kuks JB; Meijler WJ
    NeuroRehabilitation; 2010; 27(2):193-200. PubMed ID: 20871149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a muscle relaxant on sequelae of third molar surgery: a pilot study.
    Kirmeier R; Truschnegg A; Payer M; Acham S; Schulz K; Jakse N
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Sep; 104(3):e8-14. PubMed ID: 17618137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological interventions for spasticity following spinal cord injury.
    Taricco M; Adone R; Pagliacci C; Telaro E
    Cochrane Database Syst Rev; 2000; 2000(2):CD001131. PubMed ID: 10796750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of thiocolchicoside in Indian patients suffering from low back pain associated with muscle spasm.
    Soonawalla DF; Joshi N
    J Indian Med Assoc; 2008 May; 106(5):331-5. PubMed ID: 18839644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use.
    Peniston JH; Gould E
    Clin Ther; 2009 Feb; 31(2):347-59. PubMed ID: 19302907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tizanidine withdrawal symptoms in stress cardiomyopathy].
    Mörkl S; Bengesser SA; Schöggl H; Bayer D; Kapfhammer HP
    Fortschr Neurol Psychiatr; 2015 Mar; 83(3):170-3. PubMed ID: 25794323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limitations of intrathecal baclofen for spastic hemiparesis following stroke.
    Kofler M; Quirbach E; Schauer R; Singer M; Saltuari L
    Neurorehabil Neural Repair; 2009 Jan; 23(1):26-31. PubMed ID: 18796543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative effectiveness of different muscle relaxants in the rehabilitation of post-stroke patients with spasticity].
    Lipták J
    Ideggyogy Sz; 2013 Nov; 66(11-12):429. PubMed ID: 24555245
    [No Abstract]   [Full Text] [Related]  

  • 18. Patient education and self-care for the management of jaw pain upon awakening: a randomized controlled clinical trial comparing the effectiveness of adding pharmacologic treatment with cyclobenzaprine or tizanidine.
    Alencar FG; Viana PG; Zamperini C; Becker A
    J Oral Facial Pain Headache; 2014; 28(2):119-27. PubMed ID: 24822235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on tizanidine for muscle spasticity and emerging indications.
    Malanga G; Reiter RD; Garay E
    Expert Opin Pharmacother; 2008 Aug; 9(12):2209-15. PubMed ID: 18671474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinically Significant Bradycardia From Tizanidine.
    Masood U; Kahlon A; Mousa O
    Am J Ther; 2018; 25(3):e385-e386. PubMed ID: 28177941
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.